Immunologic Deficiency Syndromes: all 702 studies
Page 4 of 8. Open to participants first (67), then studies with results posted, then the rest; newest registration first within each.
- Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)CompletedNCT04553705Phase 2/3
- Immunodeficiency in MSStatus unknownNCT04447937
- Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu DhabiStatus unknownNCT04422418
- Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune DefectsCompletedNCT04408950
- Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.Status unknownNCT04382508
- Systematic Screening for Primary Immunodeficiencies in Patients Hospitalized for Severe Infections in Intensive Care.Status unknownNCT04356053
- Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)Status unknownNCT04354818
- Safety, Tolerability and Immunogenicity of 4CMenB Vaccine(2 Doses) in Adults With an ImmunodeficiencyCompletedNCT04295733
- Study Through Imaging of Visceral Lymphoid Organs in Patients With SCID Who Have Recieved Bone Marrow AllograftCompletedNCT04246840
- A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1CompletedNCT04223804Phase 1
- Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious DiarrheaCompletedNCT04192487Phase 4
- Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for SCIDStatus unknownNCT04172181
- A Clinical Study to Enable Process Validation of Commercial Grade OTL-101WithdrawnNCT04140539Phase 2/3
- POC Strategies to Improve TB Care in Advanced HIV DiseaseCompletedNCT04122404Not applicable
- The Efficacy of Remote Ischemic Conditioning on Stroke-induced ImmunodeficiencyCompletedNCT04069546Not applicable
- Immunophenotype of Risk in Older Patients Admitted for PneumoniaStatus unknownNCT04062799
- Vaccination Efficacy With Metformin in Older AdultsCompletedNCT03996538Phase 1
- Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old ChildrenStatus unknownNCT03984552
- Undetectable IgE as a Sentinel Biomarker for Humoral ImmunodeficiencyCompletedNCT03968211Phase 1
- Immunoparalysis in Acute Kidney Injury After Cardiac SurgeryTerminatedNCT03922958
- Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail PatientsStatus unknownNCT03920735
- Adoptive Transfer of Haploidentical NK Cells and N-803CompletedNCT03899480Phase 1
- Minipooled-IVIG in Primary Immunodeficiency DiseaseCompletedNCT03896932Not applicable
- Presepsin as Detective Marker of Sepsis in Immunodeficiency ICU PatientsCompletedNCT03881566
- Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell TransplantationStatus unknownNCT03836690Phase 1
- Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole TherapyStatus unknownNCT03827278Not applicable
- What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?CompletedNCT03815357
- Study Evaluating IGSC 20% Flexible Dosing in Treatment-Experienced and Treatment-Naive Subjects With Primary ImmunodeficiencyWithdrawnNCT03814798Phase 3
- Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This SituationCompletedNCT03777371
- Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCIDCompletedNCT03765632Phase 1/2
- Humoral Immunodeficiency in CLL and Therapy With Subcutaneous IgCompletedNCT03730129Phase 2/3
- ENCAPSID Study : ENCApsulated Bacterial Infection and Primary, Secondary ImmunoDeficiencyStatus unknownNCT03721146
- Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)CompletedNCT03716700
- Mechanisms of Immune DeficiencyStatus unknownNCT03707782
- Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) TreatmentStatus unknownNCT03677557Phase 4
- Tolerance and Patients' Satisfaction With IGHyStatus unknownNCT03668288
- European Alpha-Mannosidosis ParticipantTerminatedNCT03651245
- GLILD Diagnosed in Children and Young Adults With Common Variable ImmunodeficiencyStatus unknownNCT03648567
- PC4PrEP: Integrating PrEP Into Primary CareCompletedNCT03617874Not applicable
- Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant PatientsCompletedNCT03609840
- HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)CompletedNCT03583138
- A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) InfectionTerminatedNCT03563742Phase 3
- Testing a Novel Dairy Protein to Counteract ImmunosenescenceCompletedNCT03557463Not applicable
- Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral ImmunodeficiencyWithdrawnNCT03492710Phase 3
- A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)CompletedNCT03407105Phase 1
- Targeted Literature Review and Subject Interviews in Wiskott-Aldrich Syndrome (WAS)CompletedNCT03399461
- Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ SyndromeCompletedNCT03383380Phase 1/2
- Immunodeficiency for Severe Epstein-Barr Virus InfectionCompletedNCT03374566
- Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency VirusCompletedNCT03369327Phase 3
- The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary ImmunodeficiencyCompletedNCT03369301
- Reality Check: An HIV Risk Reduction Serial DramaCompletedNCT03352219Not applicable
- The Benefit of 5% IVIG for Patients With Primary Immunodeficiency Disorders Who Experience Adverse Events on 10% IVIG PreparationsCompletedNCT03339778
- Feasibility of Telerehabilitation in HIV-patientsCompletedNCT03335176Not applicable
- Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined ImmunodeficiencyStatus unknownNCT03315078Phase 1/2
- Phase 4 Study of Dolutegravir (DTG) in Russian FederationCompletedNCT03314064Phase 4
- Pyridostigmine as Immunomodulator in People Living With HIVSuspendedNCT03312244Phase 2
- Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With MenCompletedNCT03310515
- Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantActive, not recruitingNCT03301168Phase 1/2
- Pediatric Primary Immunodeficiency Disease (PID) in ChinaStatus unknownNCT03252548
- Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected PatientsCompletedNCT03250910Phase 4
- The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency DiseaseCompletedNCT03211689Not applicable
- Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous IgCompletedNCT03211065Phase 2/3
- Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation CyclophosphamideCompletedNCT03188419
- Effects of Immunonutrition on Biomarkers in Traumatic Brain InjuryCompletedNCT03166449Not applicable
- Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16CompletedNCT03164967Phase 4
- Immunological Characteristics of Patients With PID and IBDStatus unknownNCT03148028
- Treatment of Adult-Onset Immunodeficiency With BortezomibStatus unknownNCT03103555Phase 2
- Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care in Kisarawe, TanzaniaCompletedNCT03098654Not applicable
- MAMAS: Mentoring Adolescent Mothers at SchoolCompletedNCT03090802Not applicable
- A Retrospective and Prospective Natural History Study of Patients With WHIM SyndromeWithdrawnNCT03087370
- Investigation of Dental Health in Children With Neutrophil Defects: A Clinical StudyCompletedNCT03069079Not applicable
- Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)CompletedNCT03054181
- Effects of a 10 Component Dietary Supplement on Health and the Quality of LifeCompletedNCT03052491Not applicable
- Immune Benefits of Consumption of Dairy Yogurt in ElderlyCompletedNCT03051425Not applicable
- A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin ProductsStatus unknownNCT03037359
- Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary ImmunodeficienciesActive, not recruitingNCT02990819Phase 2
- Cape Town Young Women's Health CoOpCompletedNCT02974998Not applicable
- Safe Generations Plus: Swaziland PMTCT LTF StudyCompletedNCT02969161
- NC Young Women's CoOpTerminatedNCT02965014Not applicable
- JSP191 Antibody Targeting Conditioning in SCID PatientsTerminatedNCT02963064Phase 1/2
- Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and OlderTerminatedNCT02960399Not applicable
- Evaluation of the Efficacy of the Sequencing Method by Gene-panelCompletedNCT02954640Not applicable
- Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel DiseaseCompletedNCT02909244
- Effect of Fermented Maillard Reacted Whey Protein on Immune FunctionCompletedNCT02895204Not applicable
- Intensive Care Unit and Secondary and Primary Immune DeficiencyCompletedNCT02888535
- IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQviaCompletedNCT02881437Phase 4
- Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined ImmunodeficiencyStatus unknownNCT02860559Phase 1
- Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or MalignanciesNo longer availableNCT02822495
- Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary InterventionTerminatedNCT02818283Not applicable
- Factors Associated With Late HIV Diagnosis in Grampian: an Epidemiological StudyCompletedNCT02804724
- Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable ImmunodeficiencyWithdrawnNCT02789397Phase 2
- Pilot Study of a New Device (Buzzy®) for Procedural Pain Relief During Needle-Related Procedures in Paediatric PatientsCompletedNCT02771600Not applicable
- Clinical Trial of Recombinant Adenovirus Type 5 AIDS VaccineStatus unknownNCT02762045Phase 1
- Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly SchedulesCompletedNCT02711228Phase 4
- Dose Optimisation of Stavudine for the Treatment of HIV InfectionCompletedNCT02670772Phase 3
- URMC Related Haplo-identical Donor BMTCompletedNCT02660281Phase 1
- Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject DrugsTerminatedNCT02659761Phase 4
- Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS PatientsCompletedNCT02651376Phase 1/2
- Community Intervention for HIV Testing & Care Linkage Among Young MSM in BulgariaCompletedNCT02639754Not applicable
- Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima PeruCompletedNCT02630082Not applicable